Pro Dex (PDEX) Capital Leases (2013 - 2014)
Pro Dex's (PDEX) quarterly Capital Leases came in at $7000.0 in Q2 2014, down 53.33% year-over-year from $15000.0 in Q2 2013, and down 22.22% quarter-over-quarter from $9000.0 in Q1 2014.
Powered by 
Analysis
Pro Dex (PDEX) Capital Leases (2013 - 2014) Analysis & Trends
Pro Dex has disclosed Capital Leases across 2 years of filings, most recently posting $7000.0 for Q2 2014.
- In Q2 2014, Capital Leases fell 53.33% year-over-year to $7000.0; the TTM figure through Jun 2014 stood at $7000.0 (down 53.33% YoY), while the FY2014 annual figure was $7000.0, down 53.33% from the prior year.
- Capital Leases came in at $7000.0 for Q2 2014 at Pro Dex, down from $9000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $17000.0 in Q1 2013 to a low of $7000.0 in Q2 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Pro Dex | 192.84 Mn | 183.45 Mn | 7.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2014 | 7,000.00 |
| Mar 31, 2014 | 9,000.00 |
| Dec 31, 2013 | 12,000.00 |
| Sep 30, 2013 | 14,000.00 |
| Jun 30, 2013 | 15,000.00 |
| Mar 31, 2013 | 17,000.00 |